MedPath

eurochemical Imaging and Mapping of Excitatory and Inhibitory Neurometabolites in Adolescents with Autism Spectrum Disorder

Recruiting
Conditions
F84
Pervasive developmental disorders
Registration Number
DRKS00009750
Lead Sponsor
niversitätsklinikum Freiburg, Zentrum für Psychische Erkrankungen, Klinik für Psychiatrie, Psychotherapie und Psychosomatik des Kindes- und Jugendalters
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

Diagnosis of an autism-spectrum-disorder; IQ = 85; otherwise healthy subjects

Exclusion Criteria

Further psychiatric, neurologic or internistic disorders that could influence concentrations of neurometabolites. Excessive consumption of alcohol or consumption of illegal drugs in the past 6 months. An IQ below 85. No consent to be informed of possible random MRI-findings.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aim of the study is the measurement and evaluation of neurometabolites concentration in youths with autism-spectrum-disorder and control subjects of the same age, as well as analyzing possible correlations between the metabolites concentration and the severity of the autistic impairments
Secondary Outcome Measures
NameTimeMethod
not applicable
© Copyright 2025. All Rights Reserved by MedPath